Jardiamet
| Dose | Size & Price | Qty |
|---|
| Fact Table | |
|---|---|
| Formula | Combination product (Empagliflozin: C23H27ClO7; Metformin HCl: C4H11N5 · HCl) |
| License | FDA approved (2015); EMA approved |
| Bioavailability | Empagliflozin ~78%; Metformin ~50–60% (oral) |
| Legal status | Prescription only (Rx) |
| Chemical Name | Empagliflozin; 1,1-dimethylbiguanide hydrochloride (metformin hydrochloride) |
| Elimination half-life | Empagliflozin ~12.4 h; Metformin ~6.2 h |
| Dosage (Strength) | 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, 12.5 mg/1000 mg tablets; twice daily with meals |
| Pregnancy | Not recommended, especially during 2nd and 3rd trimesters |
| Brands | Synjardy (Boehringer Ingelheim & Eli Lilly) |
| Protein binding | Empagliflozin ~86%; Metformin negligible |
| PubChem CID | Empagliflozin: 11949646; Metformin: 4091 |
| MedlinePlus | Empagliflozin and Metformin combination (MedlinePlus Drug Information) |
| ChEBI | Empagliflozin: 82979; Metformin: 6801 |
| ATC code | A10BD20 |
| DrugBank | Empagliflozin: DB09038; Metformin: DB00331 |
| KEGG | Empagliflozin: D10196; Metformin: D00540 |
| Routes of administration | By mouth (oral tablets) |
Synjardy is a combination drug used to treat type 2 diabetes. Empagliflozin helps the kidneys remove extra sugar from the blood through urine, while metformin lowers how much sugar the liver makes and how much sugar the body absorbs from food. Synjardy is prescribed with a balanced diet and regular exercise to help control blood sugar in adults and children ages 10 and older with type 2 diabetes. In adults with type 2 diabetes who also have heart disease, empagliflozin may also reduce the risk of death from heart-related problems.
Synjardy is taken by mouth twice daily with meals to help reduce stomach upset. The tablets should not be split or crushed.
For adults who are not already taking metformin, treatment often starts with a low dose, such as 5 mg of empagliflozin and 500 mg of metformin twice daily. The dose may be slowly increased depending on blood sugar levels and how well the medicine is tolerated. People who are already taking metformin may switch to a Synjardy dose that offers a similar or slightly higher amount of each medicine.
The exact dose depends on how well blood sugar is controlled and how well the kidneys are working. The highest recommended daily dosage is 25 mg of empagliflozin and 2000 mg of metformin.
The active ingredients in Synjardy are empagliflozin and metformin.
Before using this medication, you may want to consult a healthcare provider about the following:
Rare but serious lactic acidosis can occur with symptoms such as unusual tiredness, muscle pain, stomach pain, trouble breathing, dizziness, or feeling cold. This risk is higher in people with kidney problems, liver disease, heart failure, heavy alcohol use, dehydration, or in adults over 65.
Synjardy should not be used in people with severe kidney disease, and kidney function should be checked before starting and regularly during treatment. The medication may need to be paused around certain imaging tests with contrast dye or during surgery.
Diabetic ketoacidosis (DKA) can happen, even with normal blood sugar. Synjardy can increase the risk of ketoacidosis, a serious condition that causes nausea, vomiting, stomach pain, shortness of breath, and extreme fatigue.
Dehydration and low blood pressure are possible. Synjardy can cause fluid loss, which may lead to dizziness, lightheadedness, low blood pressure, or kidney problems, especially in older adults, people with kidney disease or those taking diuretics.
Urinary and genital infections may occur. Synjardy increases sugar in the urine, which raises the risk of yeast infections and urinary tract infections.
Low blood sugar can occur when combined with insulin or certain diabetes drugs. When taken with insulin or medications like sulfonylureas, Synjardy may increase the risk of hypoglycemia.
Foot problems and amputations have been reported. Some patients taking SGLT2 inhibitors like Synjardy have had an increased risk of lower limb amputations, especially those with prior foot ulcers, infections, poor circulation, or nerve damage.
Vitamin B12 levels may drop over time. Long-term use of metformin can lower vitamin B12 levels, which may lead to anemia or nerve symptoms.
Avoid taking or using this medication if any of the following apply:
Common side effects of Synjardy include:
More serious side effects can include severe genital or urinary infections, dangerously low blood sugar, allergic reactions, or an increased risk of lower limb amputations.
Rare but life-threatening infections of the genital area (such as necrotizing fasciitis) have been reported.
Seek medical help if you develop severe pain, fever, signs of infection, symptoms of low blood sugar, foot sores, or swelling of the face, lips, or throat.
What is Synjardy used for?
Synjardy is a prescription medication used to improve blood sugar control in adults with type 2 diabetes mellitus, along with diet and exercise.
What medications are in Synjardy?
Synjardy contains two diabetes medicines: empagliflozin, an SGLT2 inhibitor, and metformin hydrochloride, a biguanide.
How does Synjardy work?
Synjardy lowers blood sugar by helping the kidneys remove excess glucose through urine and by reducing glucose production in the liver while improving insulin sensitivity.
How should Synjardy be taken?
Synjardy is taken by mouth with meals, usually once or twice daily depending on the formulation, to help reduce stomach-related side effects.
What is the difference between Synjardy and Synjardy XR?
Synjardy XR is an extended-release version taken once daily, while regular Synjardy may be taken twice daily.
What are the most common side effects of Synjardy?
Common side effects include diarrhea, nausea, upset stomach, increased urination, urinary tract infections, and genital yeast infections.
Can Synjardy cause low blood sugar?
Synjardy alone has a low risk of causing hypoglycemia, but the risk increases if it is used with insulin or other diabetes medications that lower blood sugar.
Are there serious risks associated with Synjardy?
Serious risks include lactic acidosis from metformin, dehydration, kidney problems, and rare but serious genital infections.
Who should not take Synjardy?
Synjardy should not be used by people with severe kidney disease, metabolic acidosis, or a history of hypersensitivity to empagliflozin or metformin.
What should I do if I miss a dose of Synjardy?
If a dose is missed, it should be taken with food as soon as remembered unless it is close to the next scheduled dose, in which case the missed dose should be skipped.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (e.g., different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.